GITIII-scale is presented, a hierarchical, interpretable pan-cancer spatial transcriptomics foundation model for TME representation learning that investigates cell state-niche associations and their underlying ligand-receptor (LR) signaling pathways that recovered niche-associated state changes more accurately than existing spatial transcriptomics foundation models in cancer types unseen during training.
Abstract
In the tumor microenvironment, a cell's state is influenced by cell-cell interactions (CCIs) with neighboring cells in its niches. Identifying dysregulated CCIs that are associated with pathogenic processes pinpoints targets for drug discovery. Imaging-based spatial transcriptomics and single-cell RNA sequencing provide, respectively, single-cell spatial information and transcriptome-wide measurements needed to study CCIs, but neither modality provides both. Existing spatial transcriptomics foundation models also cannot effectively learn from spatially resolved single-cell data with full-transcriptome coverage, explicitly infer the CCI mechanisms driving cell state-niche associations, or be interpretable enough to support direct biological interpretations. Here, we present GITIII-scale, a hierarchical, interpretable pan-cancer spatial transcriptomics foundation model for TME representation learning that investigates cell state-niche associations and their underlying ligand-receptor (LR) signaling pathways. GITIII-scale uses transformers to model interactions between pairs of cells at defined spatial distances, an interpretable single-layer graph transformer without a feed-forward network to decompose how each gene in a receiver cell is influenced by each neighboring sender cell, and a graph transformer to generate cellular-neighborhood embeddings. Trained on our assembled pan-cancer database of specimen-matched scRNA-seq and imaging-based spatial transcriptomics datasets, GITIII-scale generated TME embeddings that recovered niche-associated state changes more accurately than existing spatial transcriptomics foundation models in cancer types unseen during training. A case study of an unseen breast cancer dataset further demonstrated the model's interpretability by identifying potentially drug-targetable LR pathways associated with endothelial overgrowth and tumorigenesis.
A Framework for Learning Over REgulatory-Embedding Networks (FloREN), a supervised and interpretable sample representation method that enables improved sample stratification and biomarker discovery and supports downstream analyses that found specific immune network mechanisms in immune-mediated inflammatory diseases (I...
Iñigo Clemente‐Larramendi, S. Hillion, D. Cornec et al.· bioRxiv· 0 citations
Phenoverse is introduced, an interpretable deep learning framework that learns sample-level disease state representations through cell type-aware residual encoding, prototype learning, and Perceiver-based aggregation that demonstrates that trajectory-derived genes reveal cross-cohort molecular programs and show consist...
Manoj M Wagle, Yongheng Wang, Soham Samanta et al.· bioRxiv· 0 citations
ACSCeND offers a robust, interpretable approach to profiling CSC dynamics and establishes CSC state as a clinically meaningful, pan-cancer biomarker for guiding stemness-informed therapies by integrating single-cell precision with bulk-level applicability.
Single-cell transcriptomics resolves CAR T-cell states, yet translating heterogeneous cellular signals into patient-level therapeutic response remains challenging. Existing studies primarily identify response-associated genes or cell populations through experimental and statistical analyses, but few predictive framewor...
Yawei Li, De-Yu Fang, Cheng-Sheng Mao et al.· bioRxiv· 0 citations
A deep learning model is presented for deconvoluting molecular expression from low-plex immunofluorescence imaging, paves the way for clinically implementable TIME stratification based on low-plex immunofluorescence images, and allows for standard single-cell analysis workflows to interpret multicellular expression dat...
Markus Heidrich, Daniel Nilsson, A. M. Frank et al.· npj Precision Oncology· 0 citations
Spatial transcriptomics now profiles patient cohorts at single-cell resolution, enabling analysis of disease-associated cell organization in situ. However, discovering such spatial biomarkers remains challenging because relevant structures occur at unknown scales and cell-or niche-level annotations are rarely available...
Hoeyoung Kim, Donghee Kim, Sangwook Jung et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.